The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cobimetinib plus vemurafenib (C+V) in patients (Pts) with solid tumors with BRAF V600E/d/k/R mutation: Results from the targeted agent and profiling utilization registry (TAPUR) study.
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Abbvie; AstraZeneca; Biovica; Black Diamond Therapeutics; Debiopharm Group; eFFECTOR Therapeutics; Eisai; Infinity Pharmaceuticals; Karyopharm Therapeutics; Kolon Life Sciences; Lengo Therapeutics; Loxo; OnCusp Therapeutics; PACT Pharma; Roche; Seagen; Silverback Therapeutics; Tallac Therapeutics; Tyra Biosciences; Xencor; Zentalis; Zymeworks
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Jounce Therapeutics (Inst); Klus Pharma (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
 
Michael Rothe
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Rodolfo Gutierrez
Research Funding - Immunocore (Inst); Immunocore (Inst)
 
Eugene R Ahn
Employment - Cancer Treament Centers of America
Leadership - Cancer Treament Centers of America
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Deciphera
Consulting or Advisory Role - Clariifi; Loxo; Navican
Other Relationship - Navican/ Intermountain Healthcare
 
Steven Francis Powell
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Actuate Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Vyriad (Inst)
 
John C. Krauss
Research Funding - Abbvie (Inst); Abbvie (Inst); ACCRU (Inst); Alliance for Clinical Trials in Oncology (Inst); Alliance for Clinical Trials in Oncology (Inst); Alliance for Clinical Trials in Oncology (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Cardiff Oncology; Daiichi Sankyo/Arqule (Inst); Hutchison MediPharma (Inst); Ignyta (Inst); Isofol Medical (Inst); Novartis (Inst); NSABP FOUNDATION (Inst); NSABP Foundation (Inst); Pfizer (Inst); Tempest Therapeutics (Inst); Tempest Therapeutics (Inst)
 
Christopher M. Reynolds
No Relationships to Disclose
 
Margaret von Mehren
Consulting or Advisory Role - deciphera; GlaxoSmithKline
Research Funding - ASCO (Inst); Deciphera (Inst); Genmab (Inst); Gradalis (Inst); Novartis (Inst); Solaris Health (Inst)
Patents, Royalties, Other Intellectual Property - cell line
Other Relationship - NCCN
 
Deepti Behl
Consulting or Advisory Role - AAA HealthCare; AstraZeneca; Bristol Myers Squibb Foundation; Ipsen; Janssen Oncology; Lilly; Mirati Therapeutics; Novartis; Signatera
Speakers' Bureau - AstraZeneca; Janssen Oncology
 
Carmen Julia Calfa
No Relationships to Disclose
 
Herbert Leon Duvivier
Speakers' Bureau - AstraZeneca; Guardant Health; Regeneron
 
Henry G. Kaplan
Stock and Other Ownership Interests - Abbott; Amgen; Amgen; Becton Dickinson; Bristol Myers Squibb; CVS Health; Johnson & Johnson; Merck; Procter & Gamble; UnitedHealthcare; Vertex
Consulting or Advisory Role - Criterium; Syapse
(OPTIONAL) Uncompensated Relationships - Medpace; Seagen
 
Michael B. Livingston
No Relationships to Disclose
 
Manish Sharma
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Alexion Pharmaceuticals; Amgen; Biogen; Bristol-Myers Squibb; Lilly; Medtronic; Merck; Pfizer; Regeneron
Research Funding - Abbvie (Inst); Agenus (Inst); Alexo Therapeutics (Inst); Alpine Immune Sciences (Inst); Arrys Therapeutics (Inst); Ascentage Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Compugen (Inst); Constellation Pharmaceuticals (Inst); Coordination Pharmaceuticals (Inst); CytomX Therapeutics (Inst); eFFECTOR Therapeutics (Inst); Epizyme (Inst); Exelixis (Inst); Forty Seven (Inst); Genmab (Inst); Gilead Sciences (Inst); GlaxoSmithKline/Tesaro (Inst); Helsinn Therapeutics (Inst); Ikena Oncology (Inst); InhibRx (Inst); Innovent Biologics (Inst); Jounce Therapeutics (Inst); KLUS Pharma (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Mersana (Inst); NGM Biopharmaceuticals (Inst); Odonate Therapeutics (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); PureTech (Inst); Regeneron (Inst); Samumed (Inst); Sapience Therapeutics (Inst); Seagen (Inst); Shattuck Labs (Inst); Symphogen (Inst); Syros Pharmaceuticals (Inst); Tempest Therapeutics (Inst); Treadwell Therapeutics (Inst)
 
Walter John Urba
Leadership - Leidos Biomedical Research
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Leidos Biomedical Research
 
Raegan O'Lone
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Honoraria - Sanofi
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine
Consulting or Advisory Role - Bryologyx; Cellworks; EQRx; Illumina; Scandion Oncology
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)